Vincristine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Vincristine and local guidelines before prescribing.
Vinca alkaloid cytotoxic
Mechanism
Vinca alkaloid binding tubulin.
Uses
Acute leukaemia, lymphoma, paediatric tumours.
Dosing
- Treatment toxicity checks: baseline echo and cumulative anthracycline dose (usually kept below 450 mg/m²); rituximab infusion reactions (slow first infusion, premedicate); vincristine neuropathy and constipation; methotrexate clearance (avoid NSAIDs, PPIs and co-trimoxazole during high-dose methotrexate).
Haematology: Myeloma and Lymphoma
Side effects
Peripheral neuropathy, constipation, ileus, SIADH, severe tissue damage if extravasated.
Interactions
CYP3A4 inhibitors (azoles) increase neurotoxicity.
Contraindications and cautions
Demyelinating neuropathy
Monitoring
Neurological exam, FBC, LFT
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Reduce dose in hepatic impairment
Overdose and reversal
Supportive
Special advice
Intravenous only; fatal if given intrathecally; laxatives with treatment.
More from the textbook: uses, cautions and other points
- Avoid neurotoxic drugs , especially vincristine (can cause severe weakness).
Neurology: Neuromuscular disease - SSRIs , carbamazepine, PPIs, opioids, cyclophosphamide, vincristine, MDMA | SIADH and hyponatraemia
Endocrine: Anatomy Physiology and Pharmacology - Antipsychotics. PPIs . Opioids. Cyclophosphamide, vincristine, cisplatin. MDMA .
Endocrinology: Sodium and Water disorders - Peripheral neuropathy | Isoniazid , metronidazole (long courses), nitrofurantoin, vincristine , platinum drugs (cisplatin, oxaliplatin), taxanes, bortezomib, amiodarone, phenytoin, linezolid, dapsone, colchicine, some HIV drugs, nitrous oxide (B12), alcohol
Neurology: Anatomy, Physiology and Pharmacology - Chemotherapy - vincristine, platinum drugs, taxanes, bortezomib, thalidomide.
Neurology: Neuromuscular disease - Vincristine - peripheral neuropathy , constipation and ileus; fatal if given intrathecally (given in a mini-bag, never in a syringe near intrathecal drugs).
Haematology: Anatomy Physiology and Pharmacology - Peripheral neuropathy - paraproteins (MGUS, Waldenström's, POEMS), amyloid (with carpal tunnel and autonomic symptoms), chemotherapy (vincristine, bortezomib, thalidomide).
Haematology: History and Examination - R-CHOP every 21 days for 6 cycles (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone). NICE NG52 recommends polatuzumab vedotin with R-CHP for IPI 2–5. Radiotherapy to bulky sites in selected patients.
Haematology: Myeloma and Lymphoma
Where it is discussed in the book
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Sodium and Water disorders (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Neuromuscular disease (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: History and Examination (1 mention)
- Haematology: Myeloma and Lymphoma (3 mentions)
- Oncology: Principles (3 mentions)
- Oncology: Emergencies (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
- Cell Biology: Cell structure, organelles and membrane transport (2 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)